中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
20期
1297-1300
,共4页
周远达%李强%李慧锴%崔云龙%张倜
週遠達%李彊%李慧鍇%崔雲龍%張倜
주원체%리강%리혜개%최운룡%장척
肝肉瘤样癌%治疗%预后
肝肉瘤樣癌%治療%預後
간육류양암%치료%예후
sarcomatoid hepatocellular carcinoma%treatment%prognosis
目的:探讨肝肉瘤样癌的临床特征,提高对本病诊断与治疗的认识。方法:回顾性分析天津医科大学附属肿瘤医院2009年1月至2014年4月收治的8例肝肉瘤样癌患者临床资料,并进行随访。结果:患者发病年龄平均为56.6岁,男女之比为3:1,患者术前CT或MRI有一定特征,术后病理免疫组织化学检查均表达上皮样表型。8例患者的肿瘤局部侵袭性较强,淋巴结转移率较高。所有患者均接受了手术为主的治疗,中位生存期为10.8个月(3~35个月)。结论:肝肉瘤样癌的诊断主要依靠术后病理,免疫组织化学对其诊断及鉴别诊断很有帮助。手术切除是唯一能够延长患者生存时间的治疗手段,但总体预后较差。
目的:探討肝肉瘤樣癌的臨床特徵,提高對本病診斷與治療的認識。方法:迴顧性分析天津醫科大學附屬腫瘤醫院2009年1月至2014年4月收治的8例肝肉瘤樣癌患者臨床資料,併進行隨訪。結果:患者髮病年齡平均為56.6歲,男女之比為3:1,患者術前CT或MRI有一定特徵,術後病理免疫組織化學檢查均錶達上皮樣錶型。8例患者的腫瘤跼部侵襲性較彊,淋巴結轉移率較高。所有患者均接受瞭手術為主的治療,中位生存期為10.8箇月(3~35箇月)。結論:肝肉瘤樣癌的診斷主要依靠術後病理,免疫組織化學對其診斷及鑒彆診斷很有幫助。手術切除是唯一能夠延長患者生存時間的治療手段,但總體預後較差。
목적:탐토간육류양암적림상특정,제고대본병진단여치료적인식。방법:회고성분석천진의과대학부속종류의원2009년1월지2014년4월수치적8례간육류양암환자림상자료,병진행수방。결과:환자발병년령평균위56.6세,남녀지비위3:1,환자술전CT혹MRI유일정특정,술후병리면역조직화학검사균표체상피양표형。8례환자적종류국부침습성교강,림파결전이솔교고。소유환자균접수료수술위주적치료,중위생존기위10.8개월(3~35개월)。결론:간육류양암적진단주요의고술후병리,면역조직화학대기진단급감별진단흔유방조。수술절제시유일능구연장환자생존시간적치료수단,단총체예후교차。
Objective:To discusse the clinical features of sarcomatoid hepatocellular carcinoma to improve the understanding of diagnosis and treatment for sarcomatoid hepatocellular carcinoma. Methods:Data including clinical features and follow-up from 8 pa-tients admitted in Tianjin Medical University Cancer Institute and Hospital from January 2009 to April 2014 were retrospectively ana-lyzed. Results: The average age of all patients was 56.6 years old, and the male-to-female ratio was 3:1. Preoperative CT or MRI showed specific characteristics but it was difficult to confirm diagnosis. Pathological and immunohistochemical examination revealed an expressed epithelial-like phenotype. All 8 patients had advanced local tumor invasion and high lymph node metastasis rates. These patients received surgery, and the median survival time was 10.8 months (3 months to 35 months). Conclusion:Diagnosis of sarcoma-toid hepatocellular carcinoma mainly depended on postoperative pathological examination. Immunohistochemistry was beneficial for sarcomatoid hepatocellular carcinoma diagnosis and differential diagnosis. Surgical treatment prolonged survival time, but the overall prognosis remained poor.